LEADER 04711nam 2200649Ia 450 001 9910456053203321 005 20200520144314.0 010 $a1-280-24677-4 010 $a9786610246779 010 $a0-309-58152-4 010 $a0-585-14491-5 035 $a(CKB)110986584750692 035 $a(EBL)3376089 035 $a(SSID)ssj0000266426 035 $a(PQKBManifestationID)11206711 035 $a(PQKBTitleCode)TC0000266426 035 $a(PQKBWorkID)10301177 035 $a(PQKB)11591059 035 $a(MiAaPQ)EBC3376089 035 $a(Au-PeEL)EBL3376089 035 $a(CaPaEBR)ebr10055083 035 $a(CaONFJC)MIL24677 035 $a(OCoLC)923261025 035 $a(EXLCZ)99110986584750692 100 $a19851205d1985 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aVaccine supply and innovation$b[electronic resource] /$fDivision of Health Promotion and Disease Prevention, Institute of Medicine 210 $aWashington, D.C. $cNational Academy Press$d1985 215 $a1 online resource (210 p.) 225 1 $aPublication IOM ;$vno. 85-02 300 $aDescription based upon print version of record. 311 $a0-309-03544-9 320 $aIncludes bibliographical references. 327 $a""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future"" 327 $a""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities"" 327 $a""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS"" 327 $a""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY"" 327 $a""REFERENCES AND NOTES""""6 Liability for the Production and Sale of Vaccines ""; ""STATE OF THE LAW""; ""Experience From the Swine Flu Vaccination Program""; ""Recent Trends""; ""The Issue of Punitive Damages""; ""Summary of the Legal Situation""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""REFERENCES AND NOTES""; ""7 An Approach to the Problems of Communication, Coordination, and Collaboration in Vaccine Policy""; ""HISTORICAL BACKGROUND""; ""THE EXISTING STRUCTURE""; ""Federal Agency Interactions"" 327 $a""Public-Private Sector Interactions"" 410 0$aIOM publication ;$v85-02. 606 $aVaccines$xResearch 606 $aImmunization 608 $aElectronic books. 615 0$aVaccines$xResearch. 615 0$aImmunization. 676 $a338.47615372 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910456053203321 996 $aVaccine supply and innovation$92177201 997 $aUNINA LEADER 01107nam a22002891i 4500 001 991004190039707536 005 20031010155049.0 008 031111s1978 gw a||||||||||||||||ger 020 $a3499502666 035 $ab12540249-39ule_inst 035 $aARCHE-057351$9ExL 040 $aDip.to Lingue$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l. 082 04$a838.91 082 04$a833.91 100 1 $aSchröter, Klaus$0395419 245 10$aAlfred Döblin mit selbstzeugnissen und bilddokumenten /$cdargestellt von Klaus Schröter 260 $aReinbek bei Hamburg :$bRowohlt,$c1978 300 $a157 p. :$bill. ;$c19 cm 440 0$aRowohlts monographien ;$v266 650 4$aDöblin, Alfred$vBiografia 650 4$aDöblin, Alfred$xOpere$xStudi 907 $a.b12540249$b02-04-14$c13-11-03 912 $a991004190039707536 945 $aLE012 838.91 DOB SCH$g1$i2012000211179$lle012$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i1298694x$z13-11-03 996 $aAlfred Döblin mit selbstzeugnissen und bilddokumenten$9172537 997 $aUNISALENTO 998 $ale012$b13-11-03$cm$da $e-$fger$ggw $h0$i1